Elevance Health (Elevance Health) Total Stockholders Equity : $40,608 Mil (As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Elevance Health Total Stockholders Equity?

Elevance Health's Total Stockholders Equity for the quarter that ended in Mar. 2024 was $40,608 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Elevance Health's Book Value per Share for the quarter that ended in Mar. 2024 was $174.62. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Elevance Health's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.65.

Elevance Health Total Stockholders Equity Historical Data

The historical data trend for Elevance Health's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elevance Health Total Stockholders Equity Chart

Elevance Health Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

31,728.00

33,199.00

36,060.00

36,243.00

39,306.00

Elevance Health Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															37,356.00	38,205.00	38,423.00	39,306.00	40,608.00

Elevance Health (NYSE:ELV) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Elevance Health's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(40608	-	0)	/	232.545
	=	174.62

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Elevance Health's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(4475	+	21976)	/	40608
	=	0.65

Elevance Health Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Elevance Health's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Elevance Health (Elevance Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Elevance Health Inc (NYSE:ELV) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

ELV:Mexico A58:Germany A58:Germany

Address

220 Virginia Avenue, Indianapolis, IN, USA, 46204

Website

https://www.elevancehealth.com

Elevance Health remains one of the leading health insurers in the U.S., providing medical benefits to 48 million medical members as of June 2023. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs such as Medicaid and Medicare Advantage plans, too.

Executives

Blair Williams Todt	officer: EVP and Chief Legal Officer	8735 HENDERSON ROAD, TAMPA FL 33625
Ronald W Penczek	officer: SVP, Chief Accounting Officer	120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
Mark Kaye	officer: EVP & CFO Designate	7 WORLD TRADE CENTER, 250 GREENWICH ST, NEW YORK NY 10007
Dixon Robert L Jr	director	120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
Gloria M Mccarthy	officer: EVP, Office of the CEO	WELLPOINT, INC, 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
Kendrick Charles Morgan Jr	officer: EVP & President, Commercial	220 VIRGINIA AVE, INDIANAPOLIS IN 46204
Deanna D Strable-soethout	director	C/O PRINCIPAL FINANCIAL GROUP, 711 HIGH ST., DES MOINES IA 50392
Ramiro G Peru	director	WELLPOINT, INC, 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46260
Peter D Haytaian	officer: EVP & Pres., Govt. Bus. Div.	220 VIRGINIA AVE, INDIANAPOLIS IN 46204
Susan D. Devore	director	C/O PREMIER, INC., 13034 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Ryan M. Schneider	director	1680 CAPITAL ONE DRIVE, MCLEAN VA 22102
John E Gallina	officer: SVP & Chief Accounting Officer	120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
Julie A Hill	director	WELLPOINT, INC, 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
Thomas C Zielinski	officer: EVP & General Counsel
Jeffrey D. Alter	officer: EVP, IngenioRx & Anthem Health	4330 LA JOLLA VILLAGE DRIVE, SUITE 200, SAN DIEGO CA 92122